Keppra, Keppra XR Tablets, Extended-Release Tablets, Oral Solution, and Injection

(contact us for more information on Keppra, Keppra XR Tablets, Extended-Release Tablets, Oral Solution, and Injection )
Brand NameKeppra, Keppra XR Tablets, Extended-Release Tablets, Oral Solution, and Injection
Generic Namelevetiracetam
Marketed byUCB S.A.
NDA/BLA HolderUCB
NDA/BLA NumberNDA 21-035/S-078, S-080, NDA 21-505/S-021, S-024
NDA/BLA Approval Date11/30/1999, 7/15/2003
StatusApproved
Review ClassificationStandard
REMS Approval Date4/23/2009
Class REMSNo
REMS Source Document
Boxed Warning?
Boxed Warning
Indication
Route of Administration
Mechanism of Action
Risks
Risks (MedGuide Language)
Approved Labeling
Medication Guide?
Medication Guide
Medication Guide Version
Communication Plan?
Communication Plan
Elements to Assure Safe Use?
Elements to Assure Safe Use
Implementation System?
Implementation System
Assessment Program
Assessment Program Timeline
Branded Program
Program Description
Link to Branded Program
Deemed/Approved
Approval Letters

Sources

REMS Document: from FDA Approved REMS
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111350.htm

Approval Letters: from FDA Medication Guide Website
(http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/index.cfm?fuseaction=Search.Search_Drug_Name)

Approved Labeling: from FDA Medication Guide Website
(http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/index.cfm?fuseaction=Search.Search_Drug_Name)

Medication Guide: from FDA Medication Guide Website
(http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/index.cfm?fuseaction=Search.Search_Drug_Name)

Previous page: REMS Directory Next page: REMS White Papers
 
Register for periodic industry updates:

2013-2014© 2014 ParagonRx. All rights reserved.